E 33
Pill imprint E 33 has been identified as Topiramate 50 mg.
Topiramate is used in the treatment of migraine prevention; seizure prevention; bipolar disorder; smoking cessation; obesity (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Topiramate 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Topiramate Images
- Imprint:
-
E
33 - Strength:
- 50 mg
- Color:
- Yellow
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
corn starch
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0172
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-1031 | Greenstone LLC |
Note: Inactive ingredients may vary.
Advertisement
More Topiramate resources
- Topiramate (Wolters Kluwer)
- Topiramate Sprinkle Capsules (Wolters Kluwer)
- topiramate (Cerner Multum)
- topiramate (Micromedex) - Includes Dosage Information
- Topiramate (AHFS DI)
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate (Wolters Kluwer)
Search Again
